原文出处:
1、Ridgeback Biotherapeutics LP announces publication of mAb114 results in the New England Journal of Medicine
2、A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
本文来源自生物谷,更多资讯请下载生物谷APP(http://www.bioon.com/m/)
原文出处:
1、Ridgeback Biotherapeutics LP announces publication of mAb114 results in the New England Journal of Medicine
本文来源自生物谷,更多资讯请下载生物谷APP(http://www.bioon.com/m/)
小编推荐:
中国首个埃博霉素类乳腺
折于埃博拉 雄于COVID-19:
折于埃博拉 雄于COVID-19:
折于埃博拉 雄于COVID-19: